{"transactions":[{"id":992755,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72839,"kind":"person","name":"Mukadam Sophie","position":1,"cik":"0002050122","reported_name":"Mukadam Sophie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options (right to buy)","published_at":"2025-11-20T17:37:42.000Z","date":"2025-11-18","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2026."}],"balance_after":500000,"derivative":{"exercise_price":13.53,"expiration_date":"2035-11-18","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001012975-25-000813","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2050122/000101297525000813/form4.xml","form_type":"4"}}]}